New drugs: pregabalin and omega-3-acid ethyl esters.
Hussar
Daniel A
DA
Philadelphia College of Pharmacy, University of the Sciences, PA, USA.
D004281:Docosahexaenoic Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004338:Drug Combinations; D050171:Dyslipidemias / Q000188:drug therapy; D015118:Eicosapentaenoic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D009437:Neuralgia / Q000150:complications; D010146:Pain / Q000188:drug therapy / Q000209:etiology; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D004338:Drug Combinations; D000960:Hypolipidemic Agents; D004281:Docosahexaenoic Acids; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid; D015118:Eicosapentaenoic Acid; C405603:Omacor